Skip to content
Delayed ~15 min

ALMS ALUMIS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 16 analyst firms say about ALUMIS: their latest ratings, price targets and how far the stock is from them. How it works

6.03 USD+0.18 (+3.08%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+432.5%to the avg target 32.11 USD+26.08 USD
Buy 12 · Hold 2 · Sell 0

14 rated views · 16 analyst/firm records · 16 firms

Latest report2 Sep 2026avg report date 26 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8076
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8050

Recent analyst activity · last 90 days

Our tracked history has 16 reports on ALMS from 12 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 4 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Latest observed target change: HC Wainwright lowered its target from $25.00 (set 14 Aug 2026) to $15.00 on 2 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdBrian P SkorneyConflictConflicting reports · excluded1 Sep 202627.00 USD
BenchmarkUnnamed analystBuy5 Oct 2026—
Cantor FitzgeraldEric SchmidtBuy16 Sep 2026—
Chardan Capital MarketsJanani SundararajanBuy19 May 202640.00 USD
CitigroupUnnamed analystBuy1 Sep 2026—
GuggenheimYastin SunejaHold3 Sep 2026—
H.C. WainwrightMitchell S. KapoorBuy5 Oct 202615.00 USD · 2 Sep 2026
Leerink PartnersThomas J SmithBuy10 Aug 202626.00 USD
Morgan StanleyTerence FlynnBuy2 Sep 202629.00 USD
OppenheimerJeff JonesBuy2 Sep 202637.00 USD
Raymond JamesChristopher RaymondBuy13 Aug 202646.00 USD
StifelAlex ThompsonBuy25 Feb 202644.00 USD
UBSUnnamed analystBuy6 Jan 2026—
Weiss RatingsUnnamed analyst—27 Oct 2026—
Wells FargoDerek ArchilaBuy2 Sep 202625.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:11 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.